Life Science REIT plc (LON: LABS)

Market Cap	135.10M
Revenue (ttm)	20.12M
Net Income (ttm)	-40.04M
Shares Out	350.00M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	25.51
Dividend	0.02 (5.18%)
Ex-Dividend Date	Oct 3, 2024

Volume	388,831
Open	38.00
Previous Close	38.60
Day's Range	38.00 - 38.80
52-Week Range	31.30 - 65.00
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 26, 2024

About Life Science REIT

Life Science REIT plc (the “Company”) is a closed-ended Real Estate Investment Trust (“REIT”) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange. The registered office of the Company is located at 6th Floor, 65 Gresham Street, London, EC2V 7NQ.

• Industry: REIT - Healthcare Facilities
• Sector: Real Estate
• Founded: 2021
• Country: United Kingdom
• Stock Exchange: London Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2023, Life Science REIT's revenue was 19.94 million, an increase of 26.97% compared to the previous year's 15.71 million. Losses were -21.71 million, -21.39% less than in 2022.